Clinical Trial Update: House Dust Mite Injection Immunotherapy in Elderly Patients. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating house dust mite injection immunotherapy in elderly patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Allergic Rhinitis

Drugs mentioned

• House Dust Mite Injection Immunotherapy (house dust mite allergen immunotherapy)

Snippet

Sponsor: Medical University of Silesia | Conditions: Allergen Immunotherapy in Elderly Patients | Phase 3 | Status: COMPLETED